David James VanderWeele

National Institutes of Health

Papers

1

Total Citations

8

H-Index

1

About

David James VanderWeele is a physician-scientist whose research focuses on the intersection of prostate cancer biology, advanced imaging, and therapeutic response. His work has significantly advanced the understanding of how androgen deprivation therapy (ADT) and antiandrogen treatments alter tumor biology and imaging characteristics. In his highly cited 2019 study on multiparametric MRI (mpMRI) preoperative staging in men undergoing ADT before robotic prostatectomy, VanderWeele demonstrated how hormonal therapy impacts radiographic tumor appearance and staging accuracy—a critical insight for treatment planning. This work, with 8 citations, has informed clinical decision-making in high-risk prostate cancer management. Beyond imaging, his broader contributions include investigating mechanisms of treatment resistance and exploring biomarkers for therapy response. VanderWeele’s research bridges radiology, pathology, and oncology, offering translational insights that directly impact patient care. His ability to integrate clinical observations with molecular understanding has made him a valuable voice in prostate cancer research, particularly in optimizing multimodal treatment strategies for aggressive disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy
8 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago